2m 2m 2m 2m 2m 2m 2m
Voyager Therapeu (VYGR)
NASDAQ
$3.55-$0.05 (-1.39%)
Price as of Jun 03, 2026 6:47 PM EDT- $233.8MMarket Cap
- 9.45%1-Year Change
- BiotechnologyIndustry
Voyager Therapeu (VYGR)
$3.55-$0.05 (-1.39%)
VYGR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.60 | ||
Change | +$0.01 (+0.28%) | ||
Open | $3.61 | ||
High | $3.69 | ||
Low | $3.53 | ||
Previous Close | $3.59 | ||
Volume | 450,312 | ||
30-Day Average Volume | 581,670 | ||
1-Week Change | -8.40% | ||
1-Month Change | -4.26% | ||
1-Year Change | 8.43% | ||
3-Year Change | -68.31% | ||
5-Year Change | -14.89% | ||
Fundamentals | |||
Shares Outstanding | 60.4M | ||
Total Assets | $219.3M | ||
Market Cap | $233.8M | ||
Enterprise Value | $190.5M | ||
Period: QTR TTM FY | |||
Revenue | $2.6M | ||
Net Income | -$27.9M | ||
Free Cash Flow | -$33.4M | ||
EBIT | -$27.9M | ||
EBITDA | -$27.0M | ||
Net Working Capital | $129.5M | ||
EPS | -$0.47 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 73 | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | 8 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue